Safety of regadenoson stress testing in patients with pulmonary hypertension. - Wikidata - awgldk - TriplyDB

Safety of regadenoson stress testing in patients with pulmonary hypertension.

Safety of regadenoson stress testing in patients with pulmonary hypertension.

http://www.wikidata.org/entity/Q33167948

about

Pharmacologic stress myocardial perfusion imaging in patients with pulmonary hypertension: What do we know, and what remains to be learned?

P2860

Q53583165-B8F73245-688C-47D4-ACDB-2BBD277616E6

P2860

Safety of regadenoson stress testing in patients with pulmonary hypertension.

http://www.wikidata.org/entity/Q33167948

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@ast

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@en

type

label

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@ast

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@en

prefLabel

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@ast

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@en

P1433

Q33167948-3E010F88-A1E3-4CA6-9BEE-6D20E3D30D2D

P1476

Q33167948-145CA05F-24EB-45DD-A0FB-74D6A93499E5

P2093

Q33167948-1231DD1B-955F-4ACB-AE75-0F1FBE48029C

Q33167948-13394713-5444-47CF-A85A-26E5B8030CFB

Q33167948-13C1075B-706B-4DDD-85B7-D89DD7705276

Q33167948-160640B0-B2AE-4E57-AC46-26ED11B01202

Q33167948-16AE6E36-E6CE-475A-BFED-90CF4C914DC4

Q33167948-1A74EC98-C27D-4D6C-93BD-59EAF166F378

Q33167948-30FF5BBB-163C-4F46-A2DD-6DC076F1B16A

Q33167948-42C21051-AB90-4A05-8DC1-CD3E9DE2FCBD

Q33167948-8B4BC050-D074-4643-B0A6-B7E70DED2945

Q33167948-A0738542-7A5A-4F0C-BC59-E9D766442ECE

P2860

Q33167948-2526C792-ACD7-4C54-B899-BDBD26FC1F21

Q33167948-2D1221AB-750F-42B1-B41A-115FD7767CF1

Q33167948-351DF12B-19DD-48FB-B88B-6FD5B5988833

Q33167948-53184C1E-F2BD-4B96-B22E-BCC7F9D861CB

Q33167948-5803C634-D4F4-4E5F-9C5F-5BB547A8E163

Q33167948-A1452CF4-CD22-4EA8-BB22-7DA478F47F98

Q33167948-AC29887D-3C9D-4194-84C2-36E20132883C

Q33167948-B0445B89-12A4-46C8-A0D8-5D55F78A3BBB

Q33167948-BD1DF5CB-4DA3-4826-BCEA-B00D4BE93B7E

Q33167948-C003956D-1C22-4C21-B5CD-5796D131DEDA

P2888

Q33167948-FA73DA7B-E5A4-433D-85DA-E50BD86153B7

P31

Q33167948-E11D5A8D-117D-4FEF-AD37-6EC75F5C9967

P356

Q33167948-FEDBE603-88E6-428C-B5C4-95E228E1FB29

P577

Q33167948-98806350-9A66-4DAE-ADC5-CFF3BFA4E8E9

P698

Q33167948-D77EC626-2C2A-4FE2-97C9-8800C6A1FE87

P356

S12350-016-0734-6

P1433

Journal of Nuclear Cardiology

P1476

Safety of regadenoson stress testing in patients with pulmonary hypertension.

@en

P2093

Ashraf Saleh

http://www.w3.org/2001/XMLSchema#string

Edward P Ficaro

http://www.w3.org/2001/XMLSchema#string

Hong J Yun

http://www.w3.org/2001/XMLSchema#string

James R Corbett

http://www.w3.org/2001/XMLSchema#string

John J Lazarus

http://www.w3.org/2001/XMLSchema#string

Krasimira Mikhova

http://www.w3.org/2001/XMLSchema#string

Matthew Konerman

http://www.w3.org/2001/XMLSchema#string

Michael Ghannam

http://www.w3.org/2001/XMLSchema#string

Richard L Weinberg

http://www.w3.org/2001/XMLSchema#string

Thomas Cascino

http://www.w3.org/2001/XMLSchema#string

P2860

ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging

Primary pulmonary hypertension. A national prospective study.

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Pharmacologic manipulation of coronary vascular physiology for the evaluation of coronary artery disease.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients.

Comparative study of the safety of regadenoson between patients with mild/moderate chronic obstructive pulmonary disease and asthma.

The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.

Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry.

P2888

s12350-016-0734-6

P31

scholarly article

P356

10.1007/S12350-016-0734-6

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27896702

http://www.w3.org/2001/XMLSchema#string